《ATP-生物荧光体外抗肿瘤药敏检测技术主要临床研究文献》由会员分享，可在线阅读，更多相关《ATP-生物荧光体外抗肿瘤药敏检测技术主要临床研究文献（6页珍藏版）》请在金锄头文库上搜索。
1、ATP-生物荧光体外抗肿瘤药敏检测技术主要临床研究文献综述（Review） 1、齐青萍.ATP 肿瘤体外药敏试验研究进展.实用肿 瘤杂志.2004;19(1):106-108. 2、管睿.ATP-CSA 化疗药物敏感性试验及在卵巢癌中的应用.国外医学临床生物化学与检验学分册.2003;24(5):291-292. 3、傅军、 张伟.ATP 生物荧光肿瘤体外药敏检测技术及其临床应用研究进展.中国肿瘤临床与康复.2004;11(3):274-277. 4、Sevin BU, Peng ZL,et al. Application of an ATP-bioluminescence assay in
2、human tumor chemosensitivity testing. Gynecol Oncol. 1988 Sep;31(1):191-204. 乳腺癌（Breast Cancer ） 5、Ian A Cree，Christian M Kurbacher,et al. Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity.Anti-cancer Drug 1996,7,pp.630-635. 6、Koechli OR, Avner BP,et
3、 al. Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results. J Surg Oncol. 1993 Oct;54(2):119-25. 7、Kurbacher CM, Grecu OM,et al. ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials. R
4、ecent Results Cancer Res. 2003;161:221-30. 消化道肿瘤（Gastrointestinal Cancer）8、H.Kawamura,K.Ikeda, et al.The usefulness of the ATP assay with serum-free culture for chemosensitivity testing of gastrointestinal cancer. European Journal of cancer vol33,No.6,pp.960-966,1997. 9、Mercer SJ,Somers SS,et al.Het
5、erogeneity of chemosensitivity of esophageal and gastric carcinoma. Anticancer Drugs. 2003 Jul; 14(6):397-403. 10、Jinushi K, Hirabayashi N,et al. Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer. Gan To Kagaku Ryoho. 1990 Nov;17(11):2235-9. 11、褚忠华
6、王捷等.体外药敏试验 ATP-TCA 在消化系恶性实体肿瘤化疗中的应用.2002;22(7):418-420. 结肠癌（Colorectal Cancer）12、Whitehouse PA, Knight LA,et al. Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA). Anticancer Drugs. 2003 Jun;14(5):369-75. 泌尿系肿瘤(
7、Urogenital Tumor)13、Yamada S, Deguchi T, et al. Study on chemosensitivity test of urogenital tumors by ATP assay. Nippon Hinyokika Gakkai Zasshi. 1992 Dec;83(12):2022-8. 卵巢癌（Ovarian Cancer ）14、Peter E.Andreotti,Ian A.cree, et al. Chemosensitivity testing of human tumors using a microplate adenosine
8、triphosphate luminescence assay: clinical correlation for cisolatin resisitance of ovarian carcinoma. Cancer research 1995,55,5276-5282. 15、Kurbacher CM, Cree IA,et al. Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anticancer Drugs. 1998 Jan;9(1):51-7.
9、 16、Anne T.OMeara,M.D., Berand-Uwe Sevin,M.D. Predictive value of the ATP chemosensitivity assay in Epithelial ovarian cancer. Gynecol Oncol. 2001 Nov;83(2):334-42. 17、Konecny G, Crohns C,et al. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian c
10、ancer. Gynecol Oncol. 2000 May;77(2):258-63. 18、Breidenbach M,Rein DT,et al.Individualized long term chemotherapy for recurrent ovarian after failing high-dose treatment.Anticancer drugs. 2002,13(2):173-176. 19、Outcome of ATP based tumor chemosensitivity assay direded chemotherapy in heavily pre-tre
11、ated recurrent.Ovarian Carcinoma.BMC cancer. 2003; 3(1):19. 20、韩国荣 沈玲等.ATP 体外药敏试验指导的卵巢癌预见性化疗.现代医学.2003;31 (3):148-150. 21、张凯、章文华等. ATP 生物荧光法在卵巢癌体外药敏检测中的应用.癌症进展 2003;1 (1):37-41. 22、刘珊玲、彭兰芝等.ATP-生物荧光法在肿瘤体外药物敏感性试验中的应用研究.华西医科大学.2000;31(3):330-333. 23、楼江燕 彭芝兰等.三磷酸腺苷生物发光法在卵巢癌体外化疗药物敏感性试验中的应用.华西医科大学报.2000;
12、31(4):553-556. 24、韩国荣 张林等.人卵巢癌原代培养体外药敏试验的评价.中国肿瘤临床与康复.1999;6 (5): 21-23. 膀胱癌（Bladder Cancer）25、Inoue K,Kasahara K,et al.The efficacy of ATP Sensitivity assay on intravesical prophylactic instillation for superficial bladder cancer. Nippon Hinyokika Gakkai Zasshi,1996,87(12):1281. 肝癌（Liver Cancer）26、
13、褚忠华 陈涛等.肿瘤体外药敏检测三磷酸腺苷生物发光法在肝癌化疗中的应用.中华实验骨科杂志.2002;19(3):235-236. 白血病（Leukemia）27、王琳 秦叔逮等.急性白血病化疗药物敏感性-ATP 法的临床应用.肿瘤防治研究.1996; 23(1):114-115. 黑色素瘤（Melanoma）28、Ian A Cree,Michael H neale,et al.Heterogeneity of chemosensitivity of metastatic cutaneous melanoma. Anticancer Drugs. 1999 Jun;10 pp:437-444. 29、Myatt N, Cree IA,et al. The ex vivo chemosensitivity profile of choroidal melanoma. Anticancer Drugs. 1997 Sep;8(8):756-62.
